Dr Boreham's Crucible: Telix Pharmaceuticals
Telix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions
Stay updated with breaking news from Factor Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Telix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions
Anatara Lifesciences Limited (ASX:ANR) Chair Transition Chair TransitionMelbourne, July 26, 2021 AEST (ABN Newswire) - Anatara Lifesciences ( ASX:ANR), a developer of evidence-based solutions for gastrointestinal diseases in humans and animals, is pleased to announce the transition of Dr David Brookes from Non-Executive Director to Chairman. Sue MacLeman will continue on the Board, transitioning from Chair to Non-Executive Director. The Board determined that, having successfully steered the Company following its decision to focus on the development of products and technologies in the...